Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few DNA strands. This technology allows the rapid sequencing of millions of base pairs of DNA spanning entire genomes. The launch of new generation sequencers has opened up various markets, especially in the field of research, diagnostics and personalized medicine. The major drivers for this market are the need for constant developments with the aim of achieving an increased accuracy at a lower cost. The increasing applications for this technology, its potential as a replacement for microarray technology, decreasing costs and faster turnaround time are other factors driving this market. However, a decrease in expenditure by academic institutes, dependency of researchers on grants, issues with accuracy, standardization and interpretation of complex data are the impediments to the growth of this market. The opportunities for this market are tremendous, with a wide range of applications in various fields of biological research, drug discovery, diagnostics and personalized medicine. Also, developments in processing such as pre-sequencing cloud computing bioinformatic solution present other areas of growth for this market
Next Generation Sequencers Market by Application
The next generation Sequencers is used in the fields of Diagnostics, Biomarker Discovery, Drug Discovery, Metagenomics, Agriculture and Animal Research, Personalized Medicine and others. The use of Next Generation Sequencers in the field of diagnostics has enormous potential, as it can be used in cancer diagnostics, immune disorders diagnostics, prenatal diagnostics, etc. Personalized Medicine would be an emerging market as new generation sequencers are expected to facilitate personalized treatment. The potential of this market in cancer therapy is enormous, as this technology would enable identification of oncogenic variants that would be responsive to specific drugs. This would permit a targeted therapeutic approach of treatment with less toxicity and greater effectiveness.
Next Generation Sequencers Market by Technology
Next Generation Sequencers Market can be segmented based on the type of technology used such as Sequencing by synthesis, Ion semiconductor, sequencing, Sequencing by ligation, Pyrosequencing, Single molecule, real-time (SMRT) Sequencing, Nanopore Sequencing. Nanopore Sequencing is the recent advancement in this category and is expected to lower the cost of sequencing.
Next Generation Sequencers Market by Requirements for Processing
Next Generation Sequencers Market requires a number of products and services for its execution such as Pre-sequencing Products and Services, Sequencing Instruments/Platforms, Consumables/Reagents, NGS software and informatics. As the applications for NGS are rising, the need for NGS informatics would also rise. As the volume of data generated is huge, there would be a need for its management as well as interpretation.
Next Generation Sequencers Market by End Users
Next Generation Sequencers Market by end users is segmented into Research Institutes, Academic and Government Institutions, Hospitals & Clinics, and Pharmaceutical and biotechnology Companies. Currently, Research Institutes and Academic & Government Institutions are the major end users in this market, as this market is primarily research driven. However, hospitals and clinics would be emerging users with the advent of low cost, faster and more efficient next generation sequencers. The demand for personalized medicine is likely to spur the use of next generation sequencers in hospitals and clinics.
Next Generation Sequencers Market by Geography
Next Generation Sequencers Market is segmented into North America Europe, Asia Pacific, and RoW. The Government agencies in North America provide substantial funding for research and development projects, which accounts for these regions contributing to a majority of the market share. However, Europe and Asia are expected to be emerging markets due to increased funding by Governments for research purposes.
Some of the the key players in this market are Illumina, Life Technologies, Roche, Applied Biosystems, Pacific Biosciences, Complete Genomics, Oxford Nanopore Technologies and others. In 2013, The UAB Research Foundation licensed its nanopore technology to Illumina, a giant in the Next Generation Sequencing Market. Nanopore technology is the latest technological development in Next Generation Sequencing. With this deal, Illumina would add to its existing technologies and maintain a competitive edge in the market.
High Level analysis:
The report describes the segments of next generation sequencers market. Porters five force model helps in analyzing the bargaining power of suppliers and buyers, as well as the threat posed by new entrants. Market is analyzed by the strategic moves made by competitors, which will enable stakeholders to make decisions. Investments and partnerships, especially with researchers coming up with new technologies would enable companies to stay ahead in this competitive market.
- Market segmentation by technology would help in understanding strategies adopted by companies as well as the emerging technologies in the market
- An in-depth analysis of the applications of this market identifies business opportunities
- Geographic distribution of the market would help in discovery of untapped regions
- Key drivers and opportunities enable identification of areas of growth.
Next Generation Sequencers Market Report Highlights
By Requirements for Processing
By End Users
Key Market Players
BGI, Agilent Technologies, Pacific Biosciences, Macrogen, Denovix, Roche, Illumina, Oxford Nanopore, QIAGEN, Thermo Fisher